S100A12 and bronchopulmonary dysplasia: The molecular signature of C2 aligned with established BPD pathophysiology, featuring significantly upregulated expression of key neutrophil-related genes (Siglec-5, DYSF, MGAM, MMP9, and S100A12), which are known mediators of inflammatory lung injury.